StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Vaccinex's total debt was $25.00K at Dec 31, 2024. For fiscal 2024 it was $25.00K, down 75.2% from the year before. The highest annual figure on record is $1.13M in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$25.00K-75.2%
FY2023Dec 31, 2023$101.00K-42.3%
FY2022Dec 31, 2022$175.00K-29.7%
FY2021Dec 31, 2021$249.00K-78.0%
FY2020Dec 31, 2020$1.13M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$25.00K-75.2%
Q3 FY2024Sep 30, 2024$44.00K-63.0%
Q2 FY2024Jun 30, 2024$63.00K-54.3%
Q1 FY2024Mar 31, 2024$82.00K-47.8%
Q4 FY2023Dec 31, 2023$101.00K-42.3%
Q3 FY2023Sep 30, 2023$119.00K-38.3%
Q2 FY2023Jun 30, 2023$138.00K-34.9%
Q1 FY2023Mar 31, 2023$157.00K-31.7%
Q4 FY2022Dec 31, 2022$175.00K-29.7%
Q3 FY2022Sep 30, 2022$193.00K-83.0%
Q2 FY2022Jun 30, 2022$212.00K-81.3%
Q1 FY2022Mar 31, 2022$230.00K-79.7%
Q4 FY2021Dec 31, 2021$249.00K-78.0%
Q3 FY2021Sep 30, 2021$1.13M0.0%
Q2 FY2021Jun 30, 2021$1.13M0.0%
Q1 FY2021Mar 31, 2021$1.13M–
Q4 FY2020Dec 31, 2020$1.13M–
Q3 FY2020Sep 30, 2020$1.13M–
Q2 FY2020Jun 30, 2020$1.13M–

More Vaccinex figures

See a number that looks wrong?